Trial Profile
A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of TD-5108 for the Treatment of Chronic Constipation.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Velusetrag (Primary)
- Indications Constipation
- Focus Proof of concept; Therapeutic Use
- Acronyms ACCORD
- Sponsors Theravance Biopharma
- 04 Sep 2010 New trial record